BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28194668)

  • 21. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography.
    Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM
    J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of endoscopic nasobiliary drainage for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and cholangitis after repeated clearance of common bile duct stones: experience from a Chinese center.
    Yang J; Peng JY; Pang EJ; Chen W
    Dig Endosc; 2013 Jul; 25(4):453-8. PubMed ID: 23363031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive hydration compared to standard hydration with lactated ringer's solution for prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Wang RC; Jiang ZK; Xie YK; Chen JS
    Surg Endosc; 2021 Mar; 35(3):1126-1137. PubMed ID: 32140860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?
    Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I
    World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vigorous Periprocedural Hydration With Lactated Ringer's Solution Reduces the Risk of Pancreatitis After Retrograde Cholangiopancreatography in Hospitalized Patients.
    Choi JH; Kim HJ; Lee BU; Kim TH; Song IH
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):86-92.e1. PubMed ID: 27311618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin].
    Montaño Loza A; García Correa J; González Ojeda A; Fuentes Orozco C; Dávalos Cobián C; Rodríguez Lomelí X
    Rev Gastroenterol Mex; 2006; 71(3):262-8. PubMed ID: 17140047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors associated with the development of hyperamylasemia and post-ERCP pancreatitis in the Cuban National Institute.
    Hernández Garcés HR; Almeida Linnet A; Abreu Vázquez M; Calzadilla Bertot L; Peña K; Andrain Sierra Y; Moutary I; Segura Fernández N
    Rev Gastroenterol Peru; 2014 Apr; 34(2):127-32. PubMed ID: 25028902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?
    Döbrönte Z; Szepes Z; Izbéki F; Gervain J; Lakatos L; Pécsi G; Ihász M; Lakner L; Toldy E; Czakó L
    World J Gastroenterol; 2014 Aug; 20(29):10151-7. PubMed ID: 25110443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 40. Rectal or intramuscular diclofenac reduces the incidence of pancreatitis afterendoscopic retrograde cholangiopancreatography.
    Uçar R; Biyik M; Uçar E; Polat İ; Çifçi S; Ataseven H; Demir A
    Turk J Med Sci; 2016 Jun; 46(4):1059-63. PubMed ID: 27513404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.